Literature DB >> 31398386

Liver Resection for Nonalcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma.

Ye Xin Koh1, Hiang Jin Tan2, Yi Xin Liew3, Nicholas Syn2, Jin Yao Teo4, Ser Yee Lee4, Brian K P Goh4, George B B Goh5, Chung Yip Chan4.   

Abstract

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD)-related hepatocellular carcinoma (HCC) is on the rise worldwide, but data on long-term outcomes after curative operations are limited. The primary aim of this study was to characterize the perioperative and long-term outcomes after liver resection. The secondary aim was to investigate the influence of the histologic severity of nonalcoholic steatohepatitis and its impact on perioperative outcomes and long-term survival.
METHODS: A total of 996 patients who underwent liver resection for HCC in our institution were analyzed. Patients were categorized into subgroups of NAFLD vs non-NAFLD HCC based on histologic evidence of hepatic steatosis. Comparisons of patients' demographic, clinical, and surgical characteristics; postoperative complications; and survival outcomes were performed.
RESULTS: Eight hundred and forty-four patients had non-NAFLD HCC and 152 patients had NAFLD HCC. Comorbidities were significantly more common in the NAFLD group (p < 0.0001). In the non-NAFLD group, larger median tumor size, higher liver cirrhosis, and lower median neutrophil to lymphocyte ratio were observed (p < 0.0001). The NAFLD group had a greater amount of intraoperative blood loss, more postoperative complications, and longer length of stay. Five-year overall survival was significantly better in the NAFLD group (p = 0.0355). Significant factors that contribute to poorer survival outcomes include age, congestive cardiac failure, Child-Pugh's class B, cirrhosis, tumor size, multinodularity, and R1 resection. For NAFLD group, patients with abnormal parenchyma showed poorer survival and 5-year overall survival rates (64.8% vs 75.6%; p = 0.2291).
CONCLUSIONS: Nonalcoholic fatty liver disease-related HCC is associated with greater surgical morbidity and post-hepatectomy liver failure. Despite this, long-term survival outcomes are favorable compared with non-NAFLD etiologies.
Copyright © 2019 American College of Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31398386     DOI: 10.1016/j.jamcollsurg.2019.07.012

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  7 in total

1.  Comparison of ultrasound guided versus CT guided radiofrequency ablation on liver function, serum PIVKA-II, AFP levels and recurrence in patients with primary hepatocellular carcinoma.

Authors:  Zusheng Yu; Guowei Li; Nianyong Yuan; Wei Ding
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

2.  Combined APRI/ALBI score to predict mortality after hepatic resection.

Authors:  P Starlinger; D S Ubl; H Hackl; J Starlinger; D M Nagorney; R L Smoot; E B Habermann; S P Cleary
Journal:  BJS Open       Date:  2021-01-08

3.  Outcomes of Liver Resection for Metabolic Dysfunction-Associated Fatty Liver Disease or Chronic Hepatitis B-Related HCC.

Authors:  Lei Liu; Si Xie; Yu-Xian Teng; Zhu-Jian Deng; Kang Chen; Hao-Tian Liu; Rong-Rui Huo; Xiu-Mei Liang; Ping-Ping Guo; Da-Long Yang; Liang Ma; Bang-De Xiang; Le-Qun Li; Jian-Hong Zhong
Journal:  Front Oncol       Date:  2022-01-20       Impact factor: 6.244

4.  Extending Surgical Resection for Hepatocellular Carcinoma Beyond Barcelona Clinic for Liver Cancer (BCLC) Stage A: A Novel Application of the Modified BCLC Staging System.

Authors:  Ian J Y Wee; Fiona N N Moe; Rehena Sultana; Reiko W T Ang; Pearly P S Quek; Brian Kim Poh Goh; Chung Yip Chan; Peng Chung Cheow; Alexander Y F Chung; Prema Raj Jeyaraj; Ye Xin Koh; Peter O P Mack; London Lucien P J Ooi; Ek Khoon Tan; Jin Yao Teo; Juinn Huar Kam; Jacelyn S S Chua; Ashley W Y Ng; Jade S Q Goh; Pierce K H Chow
Journal:  J Hepatocell Carcinoma       Date:  2022-08-17

Review 5.  Mechanisms of nonalcoholic fatty liver disease and implications for surgery.

Authors:  Ariel E Feldstein; Daniel Hartmann; Benedikt Kaufmann; Agustina Reca; Baocai Wang; Helmut Friess
Journal:  Langenbecks Arch Surg       Date:  2020-08-24       Impact factor: 3.445

Review 6.  Non-alcoholic fatty liver disease and hepatocellular carcinoma: Clinical challenges of an intriguing link.

Authors:  Lampros Chrysavgis; Ilias Giannakodimos; Panagiota Diamantopoulou; Evangelos Cholongitas
Journal:  World J Gastroenterol       Date:  2022-01-21       Impact factor: 5.742

7.  Is metabolic syndrome a risk factor in hepatectomy? A meta-analysis with subgroup analysis for histologically confirmed hepatic manifestations.

Authors:  Anastasia Murtha-Lemekhova; Juri Fuchs; Svenja Feiler; Erik Schulz; Miriam Teroerde; Eva Kalkum; Rosa Klotz; Adrian Billeter; Pascal Probst; Katrin Hoffmann
Journal:  BMC Med       Date:  2022-01-28       Impact factor: 8.775

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.